Preliminary efficacy and safety of a silicone oil-filled foldable capsular vitreous body in the treatment of severe retinal detachment

Retina

Volumn 32, Issue 4, 2012, Pages 729-741

  Lin, Xiaofeng ^a   Wang, Zhenfang ^a   Jiang, Zhaoxin ^a   Long, Chongde ^a   Liu, Yaqin ^a   Wang, Peijuan ^a   Jin, Chenjin ^a   Yi, Changxian ^a   Gao, Qianying ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

foldable capsular vitreous body; retinal detachment; silicone oil

Indexed keywords

SILICONE OIL;

ADULT; AGING; ARTICLE; BIOMICROSCOPY; CASE REPORT; CILIARY BODY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORNEA ENDOTHELIUM; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LENS IMPLANT; MALE; OPTICAL COHERENCE TOMOGRAPHY; PREOPERATIVE EVALUATION; RETINA DETACHMENT; SAFETY; SPECULAR MICROSCOPY; STATISTICAL SIGNIFICANCE; TEMPERATURE; TONOMETRY; VITRECTOMY; VITREOUS BODY;

ADULT; BIOCOMPATIBLE MATERIALS; FEMALE; HUMANS; INTRAOCULAR PRESSURE; MALE; MICROSCOPY, ACOUSTIC; MIDDLE AGED; PROSTHESES AND IMPLANTS; PROSTHESIS RETENTION; RETINAL DETACHMENT; SILICONE OILS; TOMOGRAPHY, X-RAY COMPUTED; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY; YOUNG ADULT;

EID: 84859099211     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31822b1f80     Document Type: Article

References (27)

1. Green WR, Sebag J. Vitreoretinal interface. In: Ryan SJ, eds. Retina. 4th ed. Philadelphia, PA: ElsevierMosby; 2006:1921- 1989.
2. Le Goff MM, Bishop PN. Adult vitreous structure and postnatal changes. Eye 2008;22:1214-1222.
3. Castellarin A, Grigorian R, Bhagat N, et al. Vitrectomy with silicone oil infusion in severe diabetic retinopathy. Br J Ophthalmol 2003;87:318-321. (Pubitemid 36307907)
4. Karel I, Kalvodová B. Long-term results of pars plana vitrectomy and silicone oil for complications of diabetic retinopathy. Eur J Ophthalmol 1994;4:52-58. (Pubitemid 24110397)
5. Pastor JC. Proliferative vitreoretinopathy: anoverview. Surv Ophthalmol 1998;43:3-18.
6. Quiram PA, Gonzales CR, HuW, et al. Outcomes of vitrectomy with inferior retinectomy in patients with recurrent rhegmatogenous retinal detachments and proliferative vitreoretinopathy. Ophthalmology 2006;113:2041-2047. (Pubitemid 44635708)
7. Yoon YH, Lee SU, Sohn JH, Lee SE. Result of early vitrectomy for endogenous. Klebsiella pneumoniae endophthalmitis. Retina 2003;23:366-370.
8. Cibis PA, Becker B, Okun E, Canaan S. The use of liquid silicone in retinal detachment surgery. Arch Ophthalmol 1962;68:590-599.
9. The Silicone Study Group. Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 1. Arch Ophthalmol 1992;110:770-779.
10. Azen SP, Scott IU, Flynn HW Jr, et al. Silicone oil inthe repair of complex retinal detachments. A prospective observational multicenter study. Ophthalmology 1998;105:1587-1597.
11. Soman N, Banerjee R. Artificial vitreous replacements. Biomed Mater Eng 2003;13:59-74. (Pubitemid 36286397)
12. Ichhpujani P, Jindal A, Jay Katz L. Silicone oil induced glaucoma: a review. Graefes Arch Clin Exp Ophthalmol 2009; 247:1585-1593.
13. Scott IU, Flynn HW Jr, Murray TG, et al. Outcomes of complex retinal detachment repair using 1000- vs 5000-centistoke silicone oil. Arch Ophthalmol 2005;123:473-478. (Pubitemid 40489917)
14. Bhisitkul RB, Gonzalez VH. "Heavy oil" for intraocular tamponade in retinal detachment surgery. Br J Ophthalmol 2005;89:649-650. (Pubitemid 40780565)
15. Hong Y, Chirila TV, Vijayasekaran S, et al. Biodegradation invitro and retention in the rabbit eye of crosslinked poly (1- vinyl-2-pyrrolidinone) hydrogel as a vitreous substitute. J Biomed Mater Res 1998;39:650-659. (Pubitemid 28079730)
16. Maruoka S, Matsuura T, Kawasaki K, et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res 2006;31:599-606. (Pubitemid 44179986)
17. la Cour M, Lux A, Heegaard S. Visual loss under silicone oil. Klin Monbl Augenheilkd 2010;227:181-184.
18. Steijns D, Stilma JS. Vitrectomy: insearch of the ideal vitreous replacement. Ned Tijdschr Geneeskd 2009;153:A433.
19. Gao Q, Mou S, Ge J, et al. A new strategy toreplace the natural vitreous by a novel capsular artificial vitreous body with pressure-control valve. Eye 2008;22:461-468. (Pubitemid 351404476)
20. Gao Q, Chen X, Ge J, et al. Refractive shifts infour selected artificial vitreous substitutes based on Gullstrand-Emsley and Liou-Brennan schematic eyes. Invest Ophthalmol Vis Sci 2009;50:3529-3534.
21. Liu Y, Jiang Z, Gao Q, et al. Technical standards of foldable capsular vitreous body regarding mechanical, optical and biocompatible properties. Artif Organs 2010;34:836-845.
22. Lin X, Ge J, Gao Q, et al. Evaluation of the flexibility, efficacy, and safety of a foldable capsular vitreous body in the treatment of severe retinal detachment. Invest Ophthalmol Vis Sci 2011; 52:374-381.
23. Zhang R,Wang T, Xie C, et al.Evaluation of supporting role of a foldable capsular vitreous body with magnetic resonance imaging in the treatment of severe retinal detachment in human eyes. Eye (Lond.) 2011;25:794-802.
24. Chen J, Gao Q, Liu Y, et al. Evaluation of morphology and functions of a foldable capsular vitreous body in the rabbit eye. J Biomed Mater Res B Appl Biomater 2011;97:396-404.
25. Honavar SG, Goyal M, Majji AB, et al. Glaucoma after pars plana vitrectomy and silicone oil injection for complicated retinal detachments. Ophthalmology 1999;106:169-176.
26. Federman JL, Schubert HD. Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery. Ophthalmology 1988;95:870-876.
27. Liu Y, Ke Q, Chen J, et al. Dexamethasone sodium phosphate sustained mechanical release in the foldable capsular vitreous body. Invest Ophthalmol Vis Sci 2010;51:1636-1642.